Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $34.6300 (2.49%) ($33.6900 - $34.7500) on Fri. May. 3, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.53% (three month average) | RSI | 44 | Latest Price | $34.6300(2.49%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -0.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(56%) ARKG(49%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -1.765% in a week (0% probabilities). VXX(-13%) TLT(-13%) VIXM(-10%) UNG(-6%) IFRA(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.765% (StdDev 3.53%) | Hourly BBV | 0 () | Intraday Trend | 1.8% | | | |
|
Resistance Level | $34.66 | 5 Day Moving Average | $33.88(2.21%) | 10 Day Moving Average | $33.53(3.28%) | 20 Day Moving Average | $34.66(-0.09%) | To recent high | -17% | To recent low | 9.3% | Market Cap | $2.573b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |